17 studies found for:    breast cancer AND premenopausal | Open Studies | United States
Show Display Options
Rank Status Study
1 Recruiting Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Condition: Breast Cancer
Intervention: Other: Blood draw and questionnaires
2 Recruiting Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Condition: Advanced, Metastatic Breast Cancer
Interventions: Drug: LEE011;   Drug: Tamoxifen;   Drug: Letrozole;   Drug: Anastrozole;   Drug: Goserelin;   Drug: LEE011 Placebo
3 Recruiting Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Conditions: Breast Cancer;   Lymphoma;   Hodgkin's Lymphoma
Interventions: Behavioral: surveys;   Other: Blood draw;   Device: Transvaginal ultrasounds
4 Unknown  Statins and Breast Cancer Biomarkers
Condition: Breast Cancer
Interventions: Drug: Atorvastatin;   Drug: Placebo
5 Recruiting Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Condition: Early Breast Cancer
Intervention: Other: Endocrine therapy interruption
6 Recruiting Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer
Conditions: Atypical Ductal Breast Hyperplasia;   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ
Interventions: Drug: metformin hydrochloride;   Other: placebo
7 Recruiting TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
Conditions: Breast Cancer;   Breast Cancer - Female
Interventions: Drug: Tamoxifen;   Drug: Ribociclib;   Drug: Goserelin
8 Recruiting PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: PD0332991;   Drug: Anastrozole;   Drug: Goserelin;   Procedure: Surgery (standard of care);   Procedure: Tumor biopsy
9 Recruiting A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer;   Hormone Receptor Positive
Intervention: Drug: Palbociclib
10 Recruiting Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Gedatolisib;   Drug: Faslodex;   Drug: Palbociclib;   Drug: Zoladex
11 Recruiting The Immune System's Response to Young Women's Breast Cancer
Conditions: Breast Cancer;   Breast Cancer and Pregnancy
Intervention:
12 Recruiting Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Conditions: BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Stage 0 Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer
Interventions: Drug: Telapristone Acetate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
13 Recruiting Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
Condition: Breast Cancer Prevention
Interventions: Drug: Metformin;   Drug: Placebo
14 Recruiting Endocrine Response in Women With Invasive Lobular Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Fulvestrant
15 Recruiting High-Risk Breast Duct Epithelium
Condition: Breast Cancer
Intervention:
16 Recruiting Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
Conditions: Breast Cancer;   Breast Carcinoma;   Malignant Neoplasm of Breast
Interventions: Biological: Mammaglobin-A DNA Vaccine;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Tamoxifen;   Drug: Exemestane;   Drug: Goserelin
17 Not yet recruiting 19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction
Condition: Breast Cancer
Intervention: Drug: CS-1000 labeled SVF cells

Indicates status has not been verified in more than two years